Skip to site menu Skip to page content
Logo Image
In Brief
Spotlight

Novo and Hims & Hers become partners to end legal feud

Hims & Hers will curb its advertising and compounded offerings, while Novo will drop its lawsuit.

Latest news

GlobalData’s key thoughts from World EPA Congress 2026

The congress opened with a plenary session that discussed and debated how to decode current disruptions seen in pharmaceutical markets globally.

Junshi receives China’s NMPA acceptance for toripalimab injection 

The NDAs cover all approved indications of toripalimab in Mainland China.

NewcelX and Eledon partner for NCEL-101 programme

The partnership draws on clinical experience from over 100 transplant patients treated with tegoprubart.

GSK sells liver disease drug candidate to Alfasigma for $690m

GSK’s linerixibat is currently under regulatory review in the US, Europe, and China, amongst other regions.

Vinay Prasad to leave the FDA again

Prasad’s departure marks another high-profile leadership change at the FDA, which is going through a period of significant change.